Astellas Pharma (4503.TSE) Q2 2025 Earnings

25AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-53
-22
9
40

Details

Expected EPS
20
Actual EPS
40
Surprise EPS
20
Surprise Percent
+96.28%

Description

Astellas Pharma (4503.TSE) has reported earnings of 40 per share for Q2 2025.

0 Comments

Share your thoughts